Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.

Laura D. Wood, Eric S. Calhoun, Natalie Silliman, Janine Ptak, Steve Szabo, Steve M. Powell, Gregory J. Riggins, Tian Li Wang, Hai Yan, Adi Gazdar, Scott E. Kern, Len Pennacchio, Kenneth W. Kinzler, Bert Vogelstein, Victor E. Velculescu

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Tyrosine kinases are major regulators of signal transduction cascades involved in cellular proliferation and have important roles in tumorigenesis. We have recently analyzed the tyrosine kinase gene family for alterations in human colorectal cancers and identified somatic mutations in seven members of this gene family. In this study we have used high-throughput sequencing approaches to further evaluate this subset of genes for genetic alterations in other human tumors. We identified somatic mutations in GUCY2F, EPHA3, and NTRK3 in breast, lung, and pancreatic cancers. Our results implicate these tyrosine kinase genes in the pathogenesis of other tumor types and suggest that they may be useful targets for diagnostic and therapeutic intervention in selected patients.

Original languageEnglish (US)
Pages (from-to)1060-1061
Number of pages2
JournalHuman mutation.
Volume27
Issue number10
StatePublished - Oct 2006

Fingerprint

Protein-Tyrosine Kinases
Mutation
Genes
Neoplasms
Pancreatic Neoplasms
Colorectal Neoplasms
Signal Transduction
Lung Neoplasms
Carcinogenesis
Cell Proliferation
Breast Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Wood, L. D., Calhoun, E. S., Silliman, N., Ptak, J., Szabo, S., Powell, S. M., ... Velculescu, V. E. (2006). Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers. Human mutation., 27(10), 1060-1061.

Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers. / Wood, Laura D.; Calhoun, Eric S.; Silliman, Natalie; Ptak, Janine; Szabo, Steve; Powell, Steve M.; Riggins, Gregory J.; Wang, Tian Li; Yan, Hai; Gazdar, Adi; Kern, Scott E.; Pennacchio, Len; Kinzler, Kenneth W.; Vogelstein, Bert; Velculescu, Victor E.

In: Human mutation., Vol. 27, No. 10, 10.2006, p. 1060-1061.

Research output: Contribution to journalArticle

Wood, LD, Calhoun, ES, Silliman, N, Ptak, J, Szabo, S, Powell, SM, Riggins, GJ, Wang, TL, Yan, H, Gazdar, A, Kern, SE, Pennacchio, L, Kinzler, KW, Vogelstein, B & Velculescu, VE 2006, 'Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.', Human mutation., vol. 27, no. 10, pp. 1060-1061.
Wood LD, Calhoun ES, Silliman N, Ptak J, Szabo S, Powell SM et al. Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers. Human mutation. 2006 Oct;27(10):1060-1061.
Wood, Laura D. ; Calhoun, Eric S. ; Silliman, Natalie ; Ptak, Janine ; Szabo, Steve ; Powell, Steve M. ; Riggins, Gregory J. ; Wang, Tian Li ; Yan, Hai ; Gazdar, Adi ; Kern, Scott E. ; Pennacchio, Len ; Kinzler, Kenneth W. ; Vogelstein, Bert ; Velculescu, Victor E. / Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers. In: Human mutation. 2006 ; Vol. 27, No. 10. pp. 1060-1061.
@article{ac8dbe0f9b3f42458bead980e0c771a0,
title = "Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.",
abstract = "Tyrosine kinases are major regulators of signal transduction cascades involved in cellular proliferation and have important roles in tumorigenesis. We have recently analyzed the tyrosine kinase gene family for alterations in human colorectal cancers and identified somatic mutations in seven members of this gene family. In this study we have used high-throughput sequencing approaches to further evaluate this subset of genes for genetic alterations in other human tumors. We identified somatic mutations in GUCY2F, EPHA3, and NTRK3 in breast, lung, and pancreatic cancers. Our results implicate these tyrosine kinase genes in the pathogenesis of other tumor types and suggest that they may be useful targets for diagnostic and therapeutic intervention in selected patients.",
author = "Wood, {Laura D.} and Calhoun, {Eric S.} and Natalie Silliman and Janine Ptak and Steve Szabo and Powell, {Steve M.} and Riggins, {Gregory J.} and Wang, {Tian Li} and Hai Yan and Adi Gazdar and Kern, {Scott E.} and Len Pennacchio and Kinzler, {Kenneth W.} and Bert Vogelstein and Velculescu, {Victor E.}",
year = "2006",
month = "10",
language = "English (US)",
volume = "27",
pages = "1060--1061",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "10",

}

TY - JOUR

T1 - Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.

AU - Wood, Laura D.

AU - Calhoun, Eric S.

AU - Silliman, Natalie

AU - Ptak, Janine

AU - Szabo, Steve

AU - Powell, Steve M.

AU - Riggins, Gregory J.

AU - Wang, Tian Li

AU - Yan, Hai

AU - Gazdar, Adi

AU - Kern, Scott E.

AU - Pennacchio, Len

AU - Kinzler, Kenneth W.

AU - Vogelstein, Bert

AU - Velculescu, Victor E.

PY - 2006/10

Y1 - 2006/10

N2 - Tyrosine kinases are major regulators of signal transduction cascades involved in cellular proliferation and have important roles in tumorigenesis. We have recently analyzed the tyrosine kinase gene family for alterations in human colorectal cancers and identified somatic mutations in seven members of this gene family. In this study we have used high-throughput sequencing approaches to further evaluate this subset of genes for genetic alterations in other human tumors. We identified somatic mutations in GUCY2F, EPHA3, and NTRK3 in breast, lung, and pancreatic cancers. Our results implicate these tyrosine kinase genes in the pathogenesis of other tumor types and suggest that they may be useful targets for diagnostic and therapeutic intervention in selected patients.

AB - Tyrosine kinases are major regulators of signal transduction cascades involved in cellular proliferation and have important roles in tumorigenesis. We have recently analyzed the tyrosine kinase gene family for alterations in human colorectal cancers and identified somatic mutations in seven members of this gene family. In this study we have used high-throughput sequencing approaches to further evaluate this subset of genes for genetic alterations in other human tumors. We identified somatic mutations in GUCY2F, EPHA3, and NTRK3 in breast, lung, and pancreatic cancers. Our results implicate these tyrosine kinase genes in the pathogenesis of other tumor types and suggest that they may be useful targets for diagnostic and therapeutic intervention in selected patients.

UR - http://www.scopus.com/inward/record.url?scp=33749151698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749151698&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 1060

EP - 1061

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 10

ER -